期刊名称：BIOMARKERS
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
|
The journal Biomarkers brings together all aspects of the rapidly growing field of biomarker research, encompassing their various uses and applications in one essential source.
The journal has enlarged its scope to include the expanding area of biomarkers of disease and now intends to include evidence-based pharmacodynamic markers. Biomarkers, now more than ever, provides a vital forum for the exchange of ideas and techniques in all areas of biomarker research. High quality papers in four main areas are accepted and manuscripts describing novel biomarkers and their subsequent validation are especially encouraged:
Biomarkers of disease: covering measurement of endogenous substances or parameters indicative of a disease process and the use of pharmacodynamic and genetic markers in evidence-based laboratory medicine and treatment (markers of efficacy);
Biomarkers of exposure: covering detection and measurement of internal exposure to drugs and other chemicals;
Biomarkers of response: including measures of endogenous substances or parameters indicative of pathological or biochemical changes both toxicodynamic and pharmacodynamic, resulting from exposure to drugs and other chemicals;
Biomarkers of susceptibility:: including genetic factors which alter susceptibility to drugs and other chemicals.
Manuscripts can describe biomarkers measured in humans or other animals in vivo or in vitro.
The emphasis will be on demonstrating relationships between markers and effects rather than methodological papers unless they describe novel techniques.
Our preference is for authors to make their initial submission for peer review as an attached word document, emailed to john.timbrell@kcl.ac.uk. For further submission details please see instructions for authors.
|
 |
Instructions to Authors
***Note to Authors: please make sure your contact address information is clearly visible on the outside of all packages you are sending to Editors.***
General Guidelines
Biomarkers is an exciting journal which brings together work on all aspects of the rapidly growing field of biomarker research, encompassing their various uses and applications in one essential source.
Biomarkers includes a section on each of the following:
Biomarkers of effect: including measures of endogenous substances or parameters indicative of biological change such as alteration in enzymes in tissues or body fluids.
Biomarkers of susceptibility or sensitivity: including genetic factors and changes in receptors which alter the susceptibility of an organism to exposure to a chemical substance.
Biomarkers of response: All three types of markers may be either in vivo or in vitro and will apply to any biological system, not just human or mammalian.
Contacting the Editors:
John A Timbrell, Pharmacy Department, King's College London, Franklin Wilkins Building, Stamford St. London SE1 8WA, UK. Tel: +44 (0)171 333 4795. Fax: +44 (0)171 333 4795. Email: john.timbrell@kcl.ac.uk
Associate Editors:
Timothy R. Fennell, CIIT, Research Triangle Park, NC, USA
Robert Lauwerys, Unit of Industrial Toxicology & Occupational Medicine, Catholic University of Louvain, Brussels, Belgium
Jeremy Nicholson, Department of Chemistry, Birkbeck College, University of London, UK
Nico P. E. Vermeulen, Department of Pharmacochemistry, Vrije Universiteit, Amsterdam, The Netherlands
Judith T. Zelikoff, Nelson Institute of Environmental Medicine, Tuxedo, NY, USA
Editorial Board
Alfred Bernard - Catholic University of Louvain, Brussels, Belgium
Paolo Boffetta - International Agency for Research on Cancer (IARC), Lyon, France
P Brandt-Rauf - Division of Environmental Health Sciences, Columbia School of Public Health, NY, USA
Kevin Chipman - University of Birmingham, UK
Charles T. Eason - Manaaki Whenua, Landcare Research NZ Ltd, Lincoln, New Zealand
Peter Farmer - University of Leicester, UK
Anders Goksoyr - Biosense Laboratories AS, Bergen, Norway
John D. Groopman - Johns Hopkins University, Baltimore, MD, USA
L¨²cia Guilhermino - Institute of Biomedical Sciences of Abel Salazar, University of Porto Portugal
Fengsheng He - Chinese Academy of Preventive Medicine, Beijing, China
Kari Hemminki - Karolinska Institute, Huddinge, Sweden
Masayuki Ikeda - Kyoto University, Japan
Sandy Kennedy - Oxford Glycosciences Ltd., Abingdon, UK
Sergei Kharitonov - National Heart and Lung Institute, London UK
Henk van Loveren - National Institute for Public Health and the Environment, Bilthoven, The Netherlands
Maurizio Manno - University of Padua, Italy
Howard Mason - Health & Safety Executive, Sheffield, UK
Pierre Mineau - National Wildlife Research Center, Hull, Quebec, Canada
Antonio Mutti - Department of Clinical Medicine, Nephrology and Health Sciences, University of Parma, Italy
Daniel Osborn - Institute for Terrestrial Ecology, Monks Wood, UK
William D. Pennie - Drug Safety Evaluation, Pfizer, CT, USA
Robert Price - King's College London, UK
Gary Rand - Florida International University, Miami, FL, USA
Steven M. Rappaport - University of North Carolina, NC, USA
Gabriele Sabbioni - Institute of Environmental and Occupational Toxicology, Airolo, Switzerland
Lee R. Shugart - L. R. Shugart & Associates, Inc., Oak Ridge, TN, USA
Edith Sim - University of Oxford, UK
Anna Soto - Tufts University School of Medicine, Boston, MA, USA
Nigel K. Spurr - SmithKline Beecham Pharmaceuticals, Harlow, UK
John J. Stegman - Woods Hole Oceanographic Institute, Woods Hole, MA, USA
Tatiana A. Tkacheva - Institute of Occupational Health, Moscow, Russia
Paolo Vineis - University of Turin, Italy
Colin Walker - RA III, Devon, UK
Jung-Der Wang - National Taiwan University College of Public Health, Taipei, Taiwan
Catherine J. Waterfield - Medicines Safety Evaluation Division, Glaxo welcome, Ware, UK
Jason Weeks - National Centre for Environmental Toxicology, WRc-NSF, UK
Chris Wild - University of Leeds, UK
Faith Williams - University of Newcastle upon Tyne, UK
|
